Chicago, Illinois — According to state and local development sources, AbbVie plans to invest $380 Million to expand in Chicago. The company plans to occupy the new space in Chicago, on or about March 1, 2029. According to the company website, AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first for patients, communities, and our world. We aim to address complex health issues and enhance people’s lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. At AbbVie, our people are dedicated to putting patients at the center of everything we do. Every breakthrough, every innovation, and every step forward is inspired by the real lives we touch—working together to improve health and bring hope to individuals and families around the world. Get to know the passionate people who make up AbbVie and the difference we strive to make, one patient at a time. Never underestimate the power and dedication of 57,000 employees around the world united in the same mission — to make a remarkable impact for our patients, improve our society and support our communities. AbbVie was founded in 2013 when we became a separate company from Abbott. Our name represents a proud connection to that legacy. Since the beginning, our mission hasn’t wavered. Our combination of focused innovation and commercial scale brings differentiated products to market that benefit patients, customers and health care providers. 

To learn more about AbbVie, visit http://www.abbvie.com/

Company Contact:
AbbVie
1 Waukegan Road
North Chicago, IL60064
Phone: 847-596-8600
LinkedIn Link: https://www.linkedin.com/company/abbvie/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.